ARVN compared with IRWD: revenue, margins and what each company keeps, and the suppliers and customers both name

ARVNArvinas, Inc.

Mkt capRevenueRevenue

IRWDIronwood Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

ARVNArvinas, Inc.

IRWDIronwood Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ARVN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.0%▲+11.66%×1.30

May 12 '26±8.5%▼−0.93%×0.11

Q1 FY26±22.1%▲+0.57%×0.03

Nov 5 '25±13.3%▲+0.31%×0.02

IRWD

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.6%▲+2.65%×0.17

May 7 '26±11.8%▼−13.66%×1.16

= impliedARVN realized, solidIRWD realized, hatchedOne scale, both sides: full bar = 29%× = |realized| ÷ impliedSource: market data

Q1 FY26

±22.4%

▼−11.35%

×0.50

Jan 2 '26±28.3%▲+26.71%×0.94

ARVNArvinas, Inc.

7.50▼−4.58%

Mkt cap$513.9MRevenue$250MQ2 FY26Revenue$263MFY25

IRWDIronwood Pharmaceuticals Inc

3.45▼−1.57%

Regular sessionNov 2 '26

Mkt cap$578.3MRevenue$113MQ2 FY26Revenue$296MFY25

Compare

Regular sessionNov 2 '26

ARVNArvinas, Inc.

IRWDIronwood Pharmaceuticals Inc

7.50▼−4.58%

Price

3.45▼−1.57%

$513.9M

Mkt cap

$578.3M

Q2 FY26$250M

Revenue

$113MQ2 FY26

FY25$263M

Revenue

$296MFY25

ARVN7.50▼−4.58%vsIRWD3.45▼−1.57%Regular sessionNov 2 '26